Vigil Neuroscience, Inc.·4

Aug 7, 6:43 PM ET

Silber Christopher 4

4 · Vigil Neuroscience, Inc. · Filed Aug 7, 2023

Insider Transaction Report

Form 4
Period: 2023-08-07
Silber Christopher
Chief Medical Officer
Transactions
  • Award

    Stock Option Grant (Right to Buy)

    2023-08-07+330,000330,000 total
    Exercise: $6.16Exp: 2033-08-07Common Stock (330,000 underlying)
Footnotes (1)
  • [F1]This stock option award was issued pursuant to the Issuer's 2021 Stock Option and Incentive Plan and shall vest as follows: 25% of the shares shall be vested on August 7, 2024 and 1/36th of the remaining shares shall vest on each monthly anniversary thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION